| Dr Gulshan Dangol, MD | |
|
1145 S Utica Ave Ste 460, Tulsa, OK 74104-4041 | |
| (918) 579-5749 | |
| (918) 579-5762 |
| Full Name | Dr Gulshan Dangol |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 15 Years |
| Location | 1145 S Utica Ave Ste 460, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134504129 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 34500 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health - Good Samaritan Hospital | Mount vernon, IL | Hospital |
| Ssm Health St Mary's Hospital -centralia | Centralia, IL | Hospital |
| St Louis University Hospital | Saint louis, MO | Hospital |
| Franklin Hospital | Benton, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Good Samaritan Regional Health Center | 1658272059 | 59 |
News Archive
HemoGenix announced today that FDA CBER has given HemoGenix its first Master File Number for an in vitro blood stem cell potency, quality and release assay (HALO-96 PQR) for cellular therapy products used for stem cell transplantation purposes. HALO-96 PQR is the first commercially available stem cell potency assay for cellular therapy products.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the recommendation by the Data Safety Monitoring Board (DSMB) to continue with the global Phase 2b clinical trial with tamibarotene in combination with chemotherapeutical agents as a first-line treatment for patients with advanced non-small-cell lung cancer.
Veeva Systems and ZS Associates today announced a strategic partnership to accelerate the life sciences industry's move to more customer-centric engagement. The companies are joining forces to deliver innovation in customer data and data science for better marketing and sales effectiveness across all channels.
Genome Research publishes online and in print today a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge genomic and epigenomic analyses of cancer.
Scientists at the Children's Center for Cancer and Blood Diseases and The Saban Research Institute of Children's Hospital Los Angeles today announced a breakthrough discovery in understanding how the body fights leukemia.
› Verified 6 days ago
| Entity Name | Good Samaritan Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487758801 PECOS PAC ID: 1658272059 Enrollment ID: O20040119000325 |
News Archive
HemoGenix announced today that FDA CBER has given HemoGenix its first Master File Number for an in vitro blood stem cell potency, quality and release assay (HALO-96 PQR) for cellular therapy products used for stem cell transplantation purposes. HALO-96 PQR is the first commercially available stem cell potency assay for cellular therapy products.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the recommendation by the Data Safety Monitoring Board (DSMB) to continue with the global Phase 2b clinical trial with tamibarotene in combination with chemotherapeutical agents as a first-line treatment for patients with advanced non-small-cell lung cancer.
Veeva Systems and ZS Associates today announced a strategic partnership to accelerate the life sciences industry's move to more customer-centric engagement. The companies are joining forces to deliver innovation in customer data and data science for better marketing and sales effectiveness across all channels.
Genome Research publishes online and in print today a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge genomic and epigenomic analyses of cancer.
Scientists at the Children's Center for Cancer and Blood Diseases and The Saban Research Institute of Children's Hospital Los Angeles today announced a breakthrough discovery in understanding how the body fights leukemia.
› Verified 6 days ago
| Entity Name | St Marys Hospital Centralia Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770687196 PECOS PAC ID: 6709788920 Enrollment ID: O20040127000118 |
News Archive
HemoGenix announced today that FDA CBER has given HemoGenix its first Master File Number for an in vitro blood stem cell potency, quality and release assay (HALO-96 PQR) for cellular therapy products used for stem cell transplantation purposes. HALO-96 PQR is the first commercially available stem cell potency assay for cellular therapy products.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the recommendation by the Data Safety Monitoring Board (DSMB) to continue with the global Phase 2b clinical trial with tamibarotene in combination with chemotherapeutical agents as a first-line treatment for patients with advanced non-small-cell lung cancer.
Veeva Systems and ZS Associates today announced a strategic partnership to accelerate the life sciences industry's move to more customer-centric engagement. The companies are joining forces to deliver innovation in customer data and data science for better marketing and sales effectiveness across all channels.
Genome Research publishes online and in print today a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge genomic and epigenomic analyses of cancer.
Scientists at the Children's Center for Cancer and Blood Diseases and The Saban Research Institute of Children's Hospital Los Angeles today announced a breakthrough discovery in understanding how the body fights leukemia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gulshan Dangol, MD 1145 S Utica Ave Ste 460, Tulsa, OK 74104-4041 Ph: (918) 579-5749 | Dr Gulshan Dangol, MD 1145 S Utica Ave Ste 460, Tulsa, OK 74104-4041 Ph: (918) 579-5749 |
News Archive
HemoGenix announced today that FDA CBER has given HemoGenix its first Master File Number for an in vitro blood stem cell potency, quality and release assay (HALO-96 PQR) for cellular therapy products used for stem cell transplantation purposes. HALO-96 PQR is the first commercially available stem cell potency assay for cellular therapy products.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the recommendation by the Data Safety Monitoring Board (DSMB) to continue with the global Phase 2b clinical trial with tamibarotene in combination with chemotherapeutical agents as a first-line treatment for patients with advanced non-small-cell lung cancer.
Veeva Systems and ZS Associates today announced a strategic partnership to accelerate the life sciences industry's move to more customer-centric engagement. The companies are joining forces to deliver innovation in customer data and data science for better marketing and sales effectiveness across all channels.
Genome Research publishes online and in print today a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge genomic and epigenomic analyses of cancer.
Scientists at the Children's Center for Cancer and Blood Diseases and The Saban Research Institute of Children's Hospital Los Angeles today announced a breakthrough discovery in understanding how the body fights leukemia.
› Verified 6 days ago
Prasoon Kumar Yendluri, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-502-1900 Fax: 918-494-6303 | |
Janet Elizabeth Cheek, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 | |
Edie Ann Carey, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 | |
Dr. Brandon Micheal Bailey, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2811 E 15th St Ste 102, Tulsa, OK 74104 Phone: 918-935-3240 Fax: 918-935-3241 | |
Kendra Wilson, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-502-1900 Fax: 918-494-6303 | |
Radhika Kothakota, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-488-6045 Fax: 918-488-6098 |